

Glycomic Enzyme Market Scope: Industry Analysis,
Market Size, Growth, Trends Till 2031
Request Sample Report
The Glycomic Enzyme market is experiencing robust growth, driven by increasing research in glycomics applications and biotechnology. Valued at approximately $400 million in 2023, the market is projected to expand significantly due to rising demand for enzyme-based diagnostics and therapeutics, alongside advancements in biotechnology and personalized medicine. Request Sample Report
◍ Merck KGaA
◍ Agilent Technologies
◍ Thermo Fisher Scientific
◍ New England Biolabs
◍ Shimadzu Corporation
◍ Takara Bio
◍ S-BIO
◍ Sumitomo Bakelite Co. Ltd.
◍ Waters Corporation
◍ Asparia Glycomics S.L.
◍ Ludger Ltd.
◍ RayBiotech
The glycomic enzyme market features companies like Merck KGaA, Agilent Technologies, and Thermo Fisher Scientific, which offer essential tools and reagents for glycobiology research. These firms drive market growth through innovative products, partnerships, and technologies enhancing glycomic studies. Sales revenues vary, reflecting strong demand for glycomic solutions across sectors.
Request Sample Report
◍ Drug Discovery and Development
◍ Disease Diagnostics
◍ Other Applications
◍ Glycosidases and Neuramidases
◍ Glycosyltransferases and Sialytransferases
Request Sample Report
Request Sample Report
$ X Billion USD